Obesity – Page 23

Eli Lilly’s Zepbound Shows Promising Results in Reducing Sleep Apnea Severity in Pivotal Trials

2 years ago talkbio0Tagged Continuous Positive Airway Pressure, Eli, Eli Lilly, Glucagon-Like Peptide-1 Receptor, Obesity, Sleep Apnea, Obstructive, tirzepatide, trials, Weight Loss, Zepbound

Eli Lilly, Zepbound, Sleep Apnea, Obstructive Sleep Apnea (OSA), Pivotal Trials, Obesity, GLP-1 Receptor Agonist, Tirzepatide, CPAP, Weight Loss

Medicare Coverage Gap Linked to Reduced Prescription Rates for GLP-1 Weight Loss Drugs

2 years ago talkbio0Tagged Glucagon-Like Peptide 1, Health Care Costs, liraglutide, Lower prescription rates, Medicare, Mounjaro, Obesity, Saxenda, semaglutide, tirzepatide, Truveta study, Wegovy

GLP-1 drugs, Medicare coverage gap, Lower prescription rates, Obesity treatment, Semaglutide (Wegovy), Tirzepatide (Mounjaro), Liraglutide (Saxenda), Healthcare costs, Truveta study

Amgen’s obesity drug takes the weight off and may keep it off, too, early data suggest

2 years ago talkbio0Tagged Amgen's, MariTide, Obesity, Source, Weight Loss, weight off

Obesity, MariTide, Weight Loss, Source, Amgen’s, weight off

Amgen’s MariTide Sparks Speculation with Promising Early Trial Data in the Heated Obesity Market

2 years ago talkbio0Tagged MariTide, Market, Obesity

Obesity, MariTide, Market